1. Home
  2. BLBD vs IRON Comparison

BLBD vs IRON Comparison

Compare BLBD & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blue Bird Corporation

BLBD

Blue Bird Corporation

HOLD

Current Price

$70.65

Market Cap

2.3B

ML Signal

HOLD

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$73.84

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLBD
IRON
Founded
1927
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.9B
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
BLBD
IRON
Price
$70.65
$73.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
11
Target Price
$68.00
$103.18
AVG Volume (30 Days)
408.8K
560.7K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
22.78
N/A
EPS
1.84
N/A
Revenue
$1,480,099,000.00
N/A
Revenue This Year
$5.87
N/A
Revenue Next Year
$6.83
$283.52
P/E Ratio
$41.33
N/A
Revenue Growth
9.87
N/A
52 Week Low
$42.95
$40.00
52 Week High
$83.39
$99.50

Technical Indicators

Market Signals
Indicator
BLBD
IRON
Relative Strength Index (RSI) 39.51 48.34
Support Level $60.73 $70.29
Resistance Level $73.75 $82.65
Average True Range (ATR) 2.82 3.37
MACD -0.81 -0.51
Stochastic Oscillator 16.52 19.65

Price Performance

Historical Comparison
BLBD
IRON

About BLBD Blue Bird Corporation

Blue Bird Corp is an American bus manufacturing company. It is an independent designer and manufacturer of school buses. The company operates in two segments; the Bus segment which involves the design, engineering, manufacture, and sales of school buses and extended warranties; and the Parts segment which includes the sales of replacement bus parts. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada and Rest of the world.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: